These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 7586147)

  • 1. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
    Shane BS; Lockhart AM; Winston GW; Tindall KR
    Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
    Recio L; Pluta LJ; Meyer KG
    Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene.
    Cunningham ML; Foley J; Maronpot RR; Matthews HB
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):562-7. PubMed ID: 2000642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
    Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
    Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
    Shane BS; deBoer JG; Glickman BW; Cunningham ML
    Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
    Bielas JH
    Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of in vivo genotoxicity and short-term carcinogenicity assays using F344 gpt delta transgenic rats: in vivo mutagenicity of 2,4-diaminotoluene and 2,6-diaminotoluene structural isomers.
    Toyoda-Hokaiwado N; Inoue T; Masumura K; Hayashi H; Kawamura Y; Kurata Y; Takamune M; Yamada M; Sanada H; Umemura T; Nishikawa A; Nohmi T
    Toxicol Sci; 2010 Mar; 114(1):71-8. PubMed ID: 20026473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
    Young RR; Rogers BJ; Provost GS; Short JM; Putman DL
    Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens.
    Cunningham ML; Matthews HB
    Toxicol Lett; 1995 Dec; 82-83():9-14. PubMed ID: 8597159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.